Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |